http://www.fpnotebook.com/
Dietary Supplements in Obesity
Aka: Dietary Supplements in Obesity, Obesity Management with Dietary Supplements
- See Also
- Obesity
- Obesity Management
- Obesity Medication
- General
- Most studies on these agents are too short duration
- Most studies have also been of low power
- No strong evidence that any supplements are effective
- Preparations: Ineffective Agents (Avoid these)
- Chitosan
- Pittler (1999) Eur J Clin Nutr 53:379-81
- Conjugated Linoleic Acid (CLA)
- Blankson (2000) J Nutr 130:2943-8
- Chromium Picolinate
- Ineffective with risk of Rhabdomyolysis
- Vincent (2003) Sports Med 33:213-30
- Human chorionic Growth Hormone (HCG)
- Pulled from U.S. market by FDA in 2012
- Ineffective for weight loss despite which use continues by some weight loss clinics and someOTC manufacturers
- Risk of Venous Thromboembolism, Major Depression, cardiovascular events
- FDA Consumer Update
- http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm281333.htm
- Fiber (guar gum, Psyllium)
- Yerba mate
- Licorice
- Vitamin B5
- L-Carnitine
- Dandelion (Diuretic)
- Cascara (Laxative)
- St. John's Wort (no effect on weight loss)
- Laminaria (kelp)
- Spirulina (blue green algae)
- Goggul (myrrh tree extract)
- Apple cider vinegar
- Preparations: Agents with inconsistent results or weak evidence
- Garcinia cambogia (hydroxycitric acid)
- Trials have shown conflicting results
- Glucomannan (Dietary Fiber source)
- Modest weight loss in small trials
- Hydroxymethylbutyrate or Pyruvate
- May increase Lean Body Mass
- Yohimbine
- Ginseng
- No evidence to date supporting weight loss role
- May improve Glucose tolerance in diabetics
- Sotaniemi (1995) Diabetes Care 18:1373-5
- Green Tea
- Pyruvate
- Raspberry Ketone
- Artificially synthesized to flavor food or as perfume in cosmetics
- Animal studies may show benefit in lipid metabolism
- No human studies to demonstrate benefit in weight loss
- No safety data for doses or frequency used for weight loss
- Palpitations have been reported
- Warfarin drug interaction reported (reduced Warfarin effect)
- References
- (2012) Presc Lett 19(5): 29
- Dihydroepiandrosterone (DHEA)
- Sex hormone precursor (Testosterone, Estrogen)
- May reduce abdominal fat
- May increase Insulin sensitivity
- Long-term safety unclear
- Risk of Breast Cancer and Prostate Cancer
- References
- (2004) JAMA 292:2243
- Preparations: Agents with significant safety concerns (do not use)
- Avoid Ephedra
- Significant adverse effects (see Ephedra for risks)
- Marginal benefit in weight loss (1 kg)
- Shekelle (2003) JAMA 289:1537-45
- Resources
- See Dietary Supplement Resources
- References
- Prittler (2004) Am J Clin Nutr 79:529-36
- Saper (2004) Am Fam Physician 70:1731-38